BACKGROUND: Accumulation in the brain of small aggregates of amyloid beta-protein 42 (Abeta42) is the major pathogenic event of Alzheimer disease (AD). In familial early-onset AD this event is likely the result of Abeta42 overproduction; in the most common sporadic late-onset form of the disease the mechanisms of Abeta42 accumulation are unknown. METHODS: To address this issue the authors analyzed plasma levels of Abeta42 in 88 elderly patients with amnestic mild cognitive impairment (MCI), chosen as paradigm of preclinical sporadic AD. RESULTS: The authors found a significant increase of Abeta42 plasma levels in women with MCI, in comparison to the affected men and 72 cognitively normal age-matched subjects. The levels were independent of variables in education, apolipoprotein E genotype, cholesterol, and creatinine plasma concentrations, as well as hemoglobin content. CONCLUSIONS: The elevation of Abeta42 plasma levels in women with MCI may represent a biologic explanation for the sex-dependent increased incidence of late-onset AD in women identified by epidemiologic studies.
BACKGROUND: Accumulation in the brain of small aggregates of amyloid beta-protein 42 (Abeta42) is the major pathogenic event of Alzheimer disease (AD). In familial early-onset AD this event is likely the result of Abeta42 overproduction; in the most common sporadic late-onset form of the disease the mechanisms of Abeta42 accumulation are unknown. METHODS: To address this issue the authors analyzed plasma levels of Abeta42 in 88 elderly patients with amnestic mild cognitive impairment (MCI), chosen as paradigm of preclinical sporadic AD. RESULTS: The authors found a significant increase of Abeta42 plasma levels in women with MCI, in comparison to the affected men and 72 cognitively normal age-matched subjects. The levels were independent of variables in education, apolipoprotein E genotype, cholesterol, and creatinine plasma concentrations, as well as hemoglobin content. CONCLUSIONS: The elevation of Abeta42 plasma levels in women with MCI may represent a biologic explanation for the sex-dependent increased incidence of late-onset AD in women identified by epidemiologic studies.
Authors: José A Luchsinger; Ming-Xin Tang; Joshua Miller; Ralph Green; Pankash D Mehta; Richard Mayeux Journal: Neurochem Res Date: 2006-12-27 Impact factor: 3.996
Authors: Rodrigo P Almeida; Stephanie A Schultz; Benjamin P Austin; Elizabeth A Boots; N Maritza Dowling; Carey E Gleason; Barbara B Bendlin; Mark A Sager; Bruce P Hermann; Henrik Zetterberg; Cynthia M Carlsson; Sterling C Johnson; Sanjay Asthana; Ozioma C Okonkwo Journal: JAMA Neurol Date: 2015-06 Impact factor: 18.302
Authors: T T Seppälä; S-K Herukka; T Hänninen; S Tervo; M Hallikainen; H Soininen; T Pirttilä Journal: J Neurol Neurosurg Psychiatry Date: 2010-05-16 Impact factor: 10.154
Authors: Yasuji Matsuoka; Howard F Andrews; Amanda G Becker; Audrey J Gray; Pankaj D Mehta; Mary C Sano; Arthur J Dalton; Paul S Aisen Journal: Alzheimer Dis Assoc Disord Date: 2009 Oct-Dec Impact factor: 2.703